Publicaciones
Estos documentos requieren Acrobat Reader (para PDF). Puede descargar el programa Acrobat Reader de forma gratuita desde la página de descarga de Adobe (www.adobe.com).

Noticias

Enero 08, 2016
Fresenius Kabi acquires Ready-to-Administer Drugs and U.S. Pharmaceutical Plant from Becton Dickinson

Diciembre 04, 2015
Improving the lives of the youth in South Africa

Noviembre 05, 2015
Fresenius Kabi enhances school facilities in India

Octubre 29, 2015
Continued strong sales and net income growth - Fresenius raises Group earnings guidance for 2015

Agosto 28, 2015
Fresenius Kabi announces the Ketosteril® Research Award 2016

Julio 29, 2015
Accelerating sales and earnings growth in Q2 – Fresenius raises Group earnings guidance for 2015

Abril 29, 2015
Strong start into the year – Double-digit growth in constant currency – Fresenius raises Group earnings guidance for 2015

Abril 09, 2015
Fresenius Kabi supports medical relief in Gaza and Syria

Febrero 25, 2015
Fresenius: Sales and net income reach all-time highs - 6% dividend increase proposed - Positive Group outlook for 2015

Febrero 16, 2015
Fresenius Kabi sells German oncology compounding business

Enero 26, 2015
Fresenius Kabi and Halyard Health enter Supply and Distribution Agreement for Halyard Health Elastomeric I.V. Infusion Pumps

Enero 12, 2015
Fresenius Kabi Receives FDA Status Upgrade for US Grand Island Facility

Noviembre 21, 2014
Fresenius Kabi employees from China donate a multimedia classroom to Gezan Primary School

Noviembre 17, 2014
Sierra Leone Action Receives Donation of Transfusion Medicine Equipment from Fresenius Kabi

Noviembre 06, 2014
Fresenius Kabi and Russian partners terminate joint venture agreement

Noviembre 04, 2014
Fresenius posts strong Q3 results and confirms 2014 Group outlook

Mayo 09, 2014
Fresenius Kabi expands I.V. drug business in Latin America

Mayo 06, 2014
Fresenius reports expected moderate Q1 2014, fully confirms FY 2014 outlook

Abril 25, 2014
Fresenius Kabi enters Russian joint venture

Febrero 25, 2014
Fresenius: Group net income at top end of guidance, exceeding €1 billion – Positive Group outlook for 2014 – New mid-term Group targets

Imprimir página
Enviar link a un amigo

   Fresenius Kabi Colombia a company of the Fresenius Kabi Group © Septiembre 2017 | Mapa del sitio  Información legal  Imprint